BIO

Bio-Rad Laboratories, Inc.
$368.75
-8.22 (-2.18%)
Mkt Cap 9.93B
Volume 334,372
52W Range 236.73-396.23
Sector Healthcare
Beta 1.07
EPS (TTM) 8.33 USD
P/E Ratio 44.27
Revenue (TTM) 2.59B USD
Rev Growth (5Y) +0.3%
EPS Growth (5Y) -26.3%
AlphaVal · Fair Value
What we estimate one share is worth
$418.05
Fair Value weak signal
11.8% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 2.58B 2.57B 2.67B 2.80B 2.92B 2.55B 2.31B 2.29B 2.16B 2.07B 2.02B 2.18B
Net Income 759.90M (1.84B) (637.32M) (3.63B) 4.25B 3.81B 1.76B 361.00M 114.74M 28.12M 113.09M 88.84M
EPS 27.87 -65.36 -21.82 -121.79 142.61 127.86 58.93 12.10 4.12 0.88 3.74 3.08
Free Cash Flow 374.60M 266.20M 218.26M 80.29M 535.72M 476.41M 359.37M 155.67M (10.99M) 74.50M 72.84M 136.83M
FCF / Share 13.74 9.44 7.47 2.70 17.96 16.00 12.04 5.22 -0.37 2.53 2.50 4.74
Operating CF 532.20M 455.20M 374.94M 194.45M 669.46M 584.97M 457.90M 285.49M 104.14M 216.07M 186.21M 273.31M
Total Assets 10.58B 9.36B 12.30B 13.50B 17.80B 12.97B 8.01B 5.61B 4.27B 3.85B 3.71B 3.34B
Total Debt 1.53B 1.37B 1.41B 1.39B 223.38M 225.74M 651.18M 439.43M 435.00M 434.52M 434.18M 435.98M
Cash & Equiv 531.80M 488.10M 403.80M 434.21M 470.78M 662.21M 660.67M 431.53M 383.82M 456.26M 457.55M 413.25M
Book Value 7.45B 6.57B 8.74B 9.62B 13.69B 9.88B 5.76B 4.02B 2.93B 2.58B 2.49B 2.19B
Return on Equity 0.10 -0.28 -0.07 -0.38 0.31 0.39 0.31 0.09 0.04 0.01 0.05 0.04
BIO News
Bio-Rad: Favorable Read-Across From Investor Event
Sep 10, 2026 05:38 AM · seekingalpha.com
Bio-Rad Laboratories, Inc. (BIO) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Sep 09, 2026 02:17 PM · seekingalpha.com
INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives
Sep 04, 2026 03:00 AM · globenewswire.com
Bio-Rad (BIO) Up 11.7% Since Last Earnings Report: Can It Continue?
Sep 03, 2026 08:31 AM · zacks.com
Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept.
Sep 01, 2026 03:59 AM · globenewswire.com
Bio-Rad to Participate in Fireside Chat During Wells Fargo's 21st Annual Healthcare Conference
Aug 31, 2026 05:00 AM · businesswire.com
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?
Aug 21, 2026 07:35 AM · zacks.com
Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building?
Aug 20, 2026 08:26 AM · zacks.com
BIO-key's Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET
Aug 13, 2026 01:00 PM · globenewswire.com
First Trust Advisors LP Has $424,000 Position in Bio-Rad Laboratories, Inc. $BIO
Aug 12, 2026 11:34 PM · defenseworld.net